Prophylactic surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC CO2) versus standard surgery in colorectal carcinoma at high risk of peritoneal carcinomatosis: short-term and long-term outcomes from the CHECK study – protocol for a randomised, multicentre, phase 3 trial

Localised Colon Cancer: ESMO Clinical Practice Guidelines for Diagnosis, Treatment and Follow-up

(2020) G. Argiles et al.   ANNALS OF ONCOLOGY

COVID-19 and cancer

(2020) Norman E. Sharpless   SCIENCE

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

(2019) Charlotte E L Klaver et al.   Lancet Gastroenterology & Hepatology

More questions regarding HIPEC in colorectal carcinomatosis

(2019) Benny Johnson et al.   Lancet Gastroenterology & Hepatology

HIPECT4: multicentre, randomized clinical trial to evaluate safety and efficacy of Hyperthermic intra-peritoneal chemotherapy (HIPEC) with Mitomycin C used during surgery for treatment of locally advanced colorectal carcinoma

(2018) A. Arjona-Sánchez et al.   BMC CANCER

A UNICANCER phase III trial of hyperthermic intra-peritoneal chemotherapy (HIPEC) for colorectal peritoneal carcinomatosis (PC): PRODIGE 7.

(2018) François Quenet et al.   JOURNAL OF CLINICAL ONCOLOGY

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

(2018) Willemien J. van Driel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Results of a randomized phase 3 study evaluating the potential benefit of a second-look surgery plus HIPEC in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP- NTC01226394).

(2018) Diane Goere et al.   JOURNAL OF CLINICAL ONCOLOGY

HIPEC with oxaliplatin for colorectal peritoneal metastasis: The end of the road?

(2018) Wim Ceelen   EJSO

Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO2 recirculation system and clinical translation in peritoneal carcinomatosis

(2017) Susana Sánchez-García et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Diagnostic Accuracy of CT for Local Staging of Colon Cancer: A Systematic Review and Meta-Analysis

(2016) Elias Nerad et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at the Time of Primary Curative Surgery in Patients with Colorectal Cancer at High Risk for Metachronous Peritoneal Metastases

(2016) Dario Baratti et al.   ANNALS OF SURGICAL ONCOLOGY

Usefulness of thermographic analysis to control temperature homogeneity in the development and implementation of a closed recirculating CO2 chemohyperthermia model

(2016) David Padilla-Valverde et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Intraperitoneal chemotherapy hyperthermia (HIPEC) for peritoneal carcinomatosis of ovarian cancer origin by fluid and CO2recirculation using the closed abdomen technique (PRS-1.0 Combat): A clinical pilot study

(2016) Susana Sánchez-García et al.   INTERNATIONAL JOURNAL OF HYPERTHERMIA

Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes

(2016) Nan Song et al.   JAMA Oncology

FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study

(2015) Chiara Cremolini et al.   LANCET ONCOLOGY

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study

(2015) Josep Tabernero et al.   LANCET ONCOLOGY

ExtendedRASmutations and anti-EGFR monoclonal antibody survival benefit in metastatic colorectal cancer: a meta-analysis of randomized, controlled trials

(2014) M. J. Sorich et al.   ANNALS OF ONCOLOGY

Peritoneal Carcinomatosis in T4 Colorectal Cancer: Occurrence and Risk Factors

(2014) H. C. van Santvoort et al.   ANNALS OF SURGICAL ONCOLOGY

Neoadjuvant Chemotherapy with Bevacizumab May Improve Outcome after Cytoreduction and Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) for Colorectal Carcinomatosis

(2014) Wim Ceelen et al.   ANNALS OF SURGICAL ONCOLOGY

Long-term results after proactive management for locoregional control in patients with colonic cancer at high risk of peritoneal metastases

(2014) P. Sammartino et al.   INTERNATIONAL JOURNAL OF COLORECTAL DISEASE

The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery

(2014) Arancha Prada-Villaverde et al.   JOURNAL OF SURGICAL ONCOLOGY

Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy: Experience with 1,000 Patients

(2013) Edward A. Levine et al.   JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS

Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer

(2012) J. Segelman et al.   BRITISH JOURNAL OF SURGERY

Assessment of Serosal Invasion and Criteria for the Classification of Pathological (p) T4 Staging in Colorectal Carcinoma: Confusions, Controversies and Criticisms

(2011) Colin J. R. Stewart et al.   Cancers

Prognostic factors and oncologic outcome in 146 patients with colorectal peritoneal carcinomatosis treated with cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy: Italian multicenter study S.I.T.I.L.O.

(2010) F. Cavaliere et al.   EJSO

The Clavien-Dindo Classification of Surgical Complications

(2009) Pierre A. Clavien et al.   ANNALS OF SURGERY